$100.11
1.281.30%
Last update: Jul 17, 1:03 PM
Abbott Laboratories Stock Guidance
ABTNYSE
PRO
Abbott Laboratories (ABT) last issued guidance on July 16, 2026 for Q3 2026. The company guided earnings per share in the range of $1.38 - $1.46, compared to a consensus EPS estimate of $1.42.
Compared to prior guidance, Abbott Laboratories lowered its EPS outlook from a previous range of $5.45 - $5.60.
Abbott Laboratories has issued 27 guidance updates between October 19, 2022 and July 16, 2026. During this period, the company raised its outlook 6 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Jul 16, 2026
Guidance Period
Q3 2026
EPS Guidance Range
$1.38 - $1.46
Abbott Laboratories Guidance History
Review all historical guidance issued by Abbott Laboratories, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Abbott Laboratories (ABT)?
The most recent guidance for Abbott Laboratories (ABT) was reported on July 16, 2026 for Q3 2026. The company provided earnings per share guidance in the range of $1.38 to $1.46, compared to the estimated EPS of $1.42.
What EPS range did Abbott Laboratories (ABT) guide for?
Abbott Laboratories (ABT) guided EPS in the range of $1.38 to $1.46 for Q3 2026. The consensus analyst EPS estimate is $1.42.
Did Abbott Laboratories (ABT) raise or lower guidance?
Abbott Laboratories (ABT) lowered its EPS guidance from a prior range of $5.45 - $5.60 to $1.38 - $1.46 for Q3 2026.
When did Abbott Laboratories (ABT) last issue guidance?
Abbott Laboratories (ABT) last issued guidance on July 16, 2026 for Q3 2026.
